AKB-6899

Shares of Akebia Therapeutics Inc (NASDAQ: AKBA), a biopharmaceutical company that focuses on products for the treatment of kidney diseases, were trading lower by around 0.5 percent early Tuesday morning after the company announced it plans on offering and selling $75 million worth of its...